Explore the Potential with AI-Driven Innovation
Our detailed focused library is generated on demand with advanced virtual screening and parameter assessment technology powered by the Receptor.AI drug discovery platform. This method surpasses traditional approaches, delivering compounds of better quality with enhanced activity, selectivity, and safety.
We pick out particular compounds from an extensive virtual database of more than 60 billion molecules. The preparation and shipment of these compounds are facilitated by our associate Reaxense.
In the library, a selection of top modulators is provided, each marked with 38 ADME-Tox and 32 parameters related to physicochemical properties and drug-likeness. Also, every compound comes with its best docking poses, affinity scores, and activity scores, providing a comprehensive overview.
Our top-notch dedicated system is used to design specialised libraries.
Fig. 1. The sreening workflow of Receptor.AI
Utilising molecular simulations, our approach thoroughly examines a wide array of proteins, tracking their conformational changes individually and within complexes. Ensemble virtual screening enables us to address conformational flexibility, revealing essential binding sites at functional regions and allosteric locations. Our rigorous analysis guarantees that no potential mechanism of action is overlooked, aiming to uncover new therapeutic targets and lead compounds across diverse biological functions.
Our library distinguishes itself through several key aspects:
partner
Reaxense
upacc
Q53FD0
UPID:
ZC21C_HUMAN
Alternative names:
-
Alternative UPACC:
Q53FD0; E9PJQ0; Q9BTA8; Q9H5S9
Background:
Zinc finger C2HC domain-containing protein 1C plays a crucial role in cellular processes through its involvement in DNA binding and gene expression regulation. Its unique structure, characterized by the presence of a zinc finger motif, enables specific interactions with DNA, highlighting its significance in the cellular machinery.
Therapeutic significance:
Understanding the role of Zinc finger C2HC domain-containing protein 1C could open doors to potential therapeutic strategies. Its pivotal role in gene expression and cellular regulation underscores its potential as a target for therapeutic intervention in diseases where these processes are disrupted.